Sleeping Aids Market Size, Share, Growth and Industry Analysis, By Type (Medication, Mattresses and Pillows, Sleep Apnea Devices, Other), By Application (Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy, Sleep Walking, Other), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

SLEEPING AIDS MARKET OVERVIEW

The global sleeping aids market size is estimated at USD 88.1 billion in 2025, set to expand to USD 158.18 billion by 2034, growing at a CAGR of 6.72% during the forecast period from 2025 to 2034.

The United States Sleeping Aids market size is projected at USD 28.90 billion in 2025, the Europe Sleeping Aids market size is projected at USD 21.80 billion in 2025, and the China Sleeping Aids market size is projected at USD 24.96 billion in 2025.

The rise in the obese and elderly populations, as well as an increase in individuals with sleep disorders, are driving market growth. The expanding non-refundable income and the importance of using sleep assist products contribute to the market development of sleeping aids. The growing global population's endeavor to combat this condition is expected to fuel the growth of the sleeping aids industry. The increasing use of medicine by people who have sleeping-disorder breathing is projected to have a beneficial impact on the global market for sleeping aids. This type of individual is at increased risk of infection because of the disease's various hostile repercussions.

The global market for sleep aids is very competitive and relatively fragmented. The leading industry participants are always executing various growth strategies in order keep a competitive edge. These players use innovations, mergers & acquisitions, collaborations, and partnerships to thrive in a competitive market. To supply industries with highly effective and cost-efficient solutions, the key market players are always focusing on research and development.

KEY FINDINGS

COVID-19 IMPACT

Limited Trade of Products to Sink Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic caused a global lockdown, resulting in limited trade of a variety of products, notably sleeping aids. This has an effect on the market by lowering the need for sleeping aids. Furthermore, disruptions in individual monthly income, as well as the shutdown of factories to safeguard workers in all regions, had reduced the quantity of sleeping aids products produced.

COVID-19 had a rather unfavorable effect upon the sleeping aids market growth overall. This was attributable to a decline in the need for sleeping aids for sleep disorders. Furthermore, market participants lowered the amount they invest in resources and raw materials as a result of the shutdown of production plants in all regions to protect workers.

LATEST TRENDS

Sleep-Inducing Cushions to Stimulate Market Development   

Sleep-inducing cushions and mattresses are growing more popular throughout the world, and this has had a direct impact on the expansion of the sleep products industry. Increased incidences of restless legs syndrome and sleepwalking have additionally resulted in significant income in the worldwide sleeping advertisement business. Narcolepsy is a rare disorder that can be cured and managed with sleep medicines.

• In 2023, more than 28 million wearable sleep trackers were actively used across North America and Europe, with over 62% of users aged between 25 and 45 seeking sleep improvement solutions through connected devices and smart apps.

• Across Asia-Pacific markets, over 510 million units of melatonin supplements were sold in 2023, with a year-on-year increase of 14.6%, highlighting a shift toward non-prescription sleep aids for managing mild to moderate insomnia symptoms.

Request a Free sample to learn more about this report

SLEEPING AIDS MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into medication, mattresses and pillows, sleep, apnea devices.

• Medication: Sleeping pills are tranquilizer-containing prescription drugs used for the treatment of insomnia, restless sleep, and difficulties falling asleep. There are numerous varieties of sleeping pills accessible today, each with its own chemical makeup and pharmacological impact.

• Mattresses and Pillows: The continuous development of industrial methods is likely to have an impact on the placement of mattresses and pillows. Furthermore, important qualities that promote segmental growth include simple access and use of many objects, as well as improved understanding of the health advantages of good sleep. The growing difficulty of sleeplessness will force the health organization to create new and better-organized sleeping aids. People's shifting lifestyles have a significant impact on worldwide market growth.

• Sleep Apnea Devices: The major therapy option for mild to severe sleep apnea is CPAP (consistent positive airway pressure) equipment. The CPAP machine treats disruptive sleep apnea via opening the airway and thus preventing throat collapse when trying to breathe.

By Application

Based on application the global market can be categorized into insomnia, restless legs syndrome, sleep apnea, narcolepsy, sleep walking.

• Insomnia: Insomnia occurs when you do not sleep as much as you should. This could indicate that you have trouble falling asleep enough, aren't sleeping well, or are having difficulty getting to and staying asleep. Insomnia becomes a minor annoyance for some people. Insomnia may constitute a big source of stress for others.

• Restless Legs Syndrome: RLS is a condition characterized by an uncontrollable impulse to move one's legs, frequently in response to an unpleasant sensation. It typically occurs in the middle of the day or at night, when you're seated or lying down.

• Narcolepsy: Narcolepsy is a neurological condition that causes excessive drowsiness during the day. Narcolepsy makes it difficult for people to remain awake for extended periods of time. They suddenly fall asleep. This can pose major issues in their daily lives.

• Sleep Walking: Sleepwalking, also known as somnambulism, is the act of waking up and wandering around while asleep. Sleepwalking is more prevalent in children than in adults and is usually overcome by teenagers. Isolated cases of sleepwalking do not always indicate major problems or necessitate therapy.

DRIVING FACTORS

Importance of Sleep in General Health to Support Market Expansion 

A huge opportunity exists to boost understanding of the importance of sleep in general health and well-being. More people are looking for knowledge and solutions to improve their sleep, which may increase the popularity of sleep aids. Wearable devices, smart mattresses, and smartphone apps for measuring sleep habits, for example, give opportunity for creating more effective and individualized treatments.

Advancements in Research and Development to Foster Industry Progress

The market is expanding due to a surge in the overall number of hospitals equipped with innovative instruments, advancements in research and development, and the spread of healthcare reforms. Growing elderly and obese people have led in an increase in insomnia scenarios, which is expected to increase the number individuals with sleep disorders, resulting in market growth throughout the analyzed period.

• Globally, 1 in every 4 adults in urban areas reported sleep-related issues in 2023, with chronic insomnia affecting over 220 million individuals. This has spurred high demand for therapeutic mattresses, sound machines, and pharmacological sleep aids.

• In 2023, more than 75 national health programs included sleep hygiene education as part of their mental health initiatives, reaching over 96 million people through public campaigns focused on sleep apnea and circadian rhythm disorders.

RESTRAINING FACTORS

Regulatory Barriers to Stop Market Evolution    

Many sleep aids, particularly prescription drugs, can cause sleepiness, grogginess, reliance, and even the danger of addiction. This element has prompted concerns about patient and medical staff safety. Sleep aids, especially prescription medications, are subject to stringent regulatory scrutiny. The clearance procedure for novel sleep aid drugs can be lengthy and expensive, impeding market expansion.

• Clinical data revealed that 18% of long-term users of prescription sleep aids developed tolerance or dependency symptoms in 2023, leading to a cautious approach among physicians when prescribing benzodiazepine-class and related medications.

• In countries without universal health coverage, the average cost of a single polysomnography test exceeded $900 in 2023. This financial barrier restricted access to proper diagnosis for nearly 30% of suspected sleep apnea patients, limiting downstream product demand.

• Request a Free sample to learn more about this report

•  

SLEEPING AIDS MARKET REGIONAL INSIGHTS

North America Regulation upon the Industry Owing to Increased Usage of Tobacco Products

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America had the highest sleeping aids market share segment in the industry. The rising number of sleep illnesses in the country may be attributed to the increased usage of tobacco products and alcohol intake. Furthermore, the presence of important business organizations in the United States, together with rising consumer awareness of sleep assistance and sleeping excellence goods, is expected to drive market expansion. The rise in overweight and older persons is expected to drive up the need for sleeping aids and drugs.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. The market report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.

The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market are expected to benefit from substantial growth opportunities in the near future.

• Becton Dickinson (BD): In 2023, BD distributed over 1.2 million sleep disorder diagnostic kits globally, including respiratory monitors and home-use sensors, supporting both clinical and at-home sleep assessments across more than 70 countries.

• Compumedics: Compumedics deployed over 3,800 sleep monitoring systems in hospitals and sleep labs in 2023, with a strong presence in Australia, the U.S., and parts of Asia. Its devices supported multi-parameter monitoring in both adult and pediatric sleep studies.

List of Top Sleeping Aids Companies

• Becton Dickinson
• Compumedics
• Hill-Rom
• Cadwell Laboratories
• Pfizer
• Talley Group
• Lifeline Corporation
• Teva Pharmaceuticals
• Medical Depot
• Abecca Healthcare
• Betterlifehealthcare
• GlaxoSmithKline
• Koninklijke Philips
• Natus Medical
• Merck

INDUSTRIAL DEVELOPMENT

December 2023: Eisai Co., Ltd. announced that the USFDA approved a new drug application in December 2023 for its internal disclosed and enhanced orexin antagonist bound receptor DAYVIGOTM (Lemborexant). Lemborexant, also known as DAYVIGOTM, has been approved for the treatment of insomnia symptoms in adults.

REPORT COVERAGE

This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolution trend, opportunities in the market, important market drivers, and SWOT opportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.

In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.